The use of PDX with different mutational profiles shows the efficacy of the combination on a colon tumor liver metastasis (PDX 36M1) and on a primary tumor mutated for PIK3CA and ERBB2 genes (PDX 40). The gene discussed is ERBB2; the disease is neoplasm.